Methods:
We analyzed a composite risk of repair thrombosis and/or limb amputation (RTLA) between patients who did and did not undergo ISA during arterial injury repair. Patient data was The majority were male (87%) with a mean age of 32.6 years (range 4-91) and 74% injured by penetrating mechanism. 63% of the injuries were described as arterial transection and 37% had concomitant venous injury. 62% of patients underwent ISA. RTLA occurred in 22 patients (11%) overall, with no significant difference in these outcomes between patients who received ISA and those that did not (10% vs. 14%, p = 0.6). There was, however, significantly higher total blood product use noted among patients treated with ISA versus those that did not receive ISA (median 3 units vs. 1 unit, p = 0.002). Patients treated with ISA also stayed longer in the ICU (median 3 days vs. 1 day, p = 0.001) and hospital (median 9.5 days vs. 6 days, p = 0.01).
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Discussion: In this multicenter prospective cohort, intraoperative systemic anticoagulation was not associated with a difference in rate of repair thrombosis or limb loss; but was associated with an increase in blood product requirements and prolonged hospital stay. Our data suggest there is no significant difference in outcome to support use of ISA for repair of traumatic arterial injuries.
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BACKGROUND
Routine intraoperative systemic anticoagulation (ISA) is a mainstay of therapy in elective arterial reconstruction and treatment of acute limb ischemia (1) . In the setting of trauma, surgeons have been reluctant or unable to systemically anticoagulate patients when performing arterial repair due to concern for potential local and systemic bleeding (2) . It is unclear if the improved patency seen with elective vascular repair can be generalized to traumatic arterial repair, particularly in patients with acute traumatic coagulopathy or resuscitation-associated coagulopathy. There is limited and conflicting retrospective data in the literature correlating improved patency or limb salvage with use of ISA during traumatic arterial injury repair (3) (4) (5) (6) (7) (8) (9) .
Retrospective reviews of patients who received ISA during lower extremity arterial injury repair report a limb salvage rate of 85-91% (2, 5, 7, 8) . Other reviews, however, report lower limb salvage rates of 83-84% with similar injuries, despite routinely not giving ISA (4, 10).
Comparative studies have shown no statistically significant difference in outcome between patients who are given ISA and those who are not (6, 7) . Proponents, however, argue that the risks of ISA are minimal, and may decrease the risk of distal in situ thrombus or microvascular thrombosis (5, 9) . We hypothesized that intraoperative systemic anticoagulation (ISA) decreased the risk of repair thrombosis or limb amputation (RTLA) after traumatic vascular injury of the extremities. Patients treated with vein interposition or bypass, vein patch or autologous artery as a conduit were included in the autologous category. ISA was defined as systemic anticoagulation with unfractionated heparin (UFH) utilized during the initial operation or vascular repair.
METHODS
Intraoperative regional anticoagulation was not included in this study. The total mangled extremity severity score (MESS) was calculated as originally described by Johansen et al., from the prospectively obtained components described in Appendix A (12).
The primary endpoint was a composite risk of RTLA during the index admission, between patients who did and did not undergo ISA during arterial injury repair. Secondary endpoints included need for reintervention after initial operation for any reason, total units of packed red blood cells (PRBC) required in the first 24 hours, length of intensive care unit (ICU) stay and length of total hospital stay. 8 Statistical analysis was performed using Stata Version 14.1 (StataCorp, College Station, TX, USA). Differences in demographics for patients who received ISA and were compared using the Wilcoxon rank-sum test for ordinal variables and two-sample t-test for continuous variables. The Fisher's exact test was used for 2x2 contingency tables with 20 or less patients in any category. P-values are reported as double the 1-sided exact probability. Pearson's chisquared test with Yates' correction for continuity was used for 2x2 contingency tables when there were between 21 and 40 patients in a given category. Pearson's chi-squared test was used for all larger contingency tables. A p-value < 0.05 was considered statistically significant. ISA was given to 119 patients in total (62%). The patients were predominantly male, with a mean age of 32.6 years (range 4-91, Table 1 ). Men were more likely to receive ISA than women (92% ISA were male vs. 78% without ISA were male, p = 0.02). Most injuries were penetrating in nature (74%), and were most often caused by gunshot wounds (42%). The injury identified was most often a transection (63%). There were no differences in ISS, admission systolic blood pressure, or Glasgow coma score (GCS) between patients who received ISA and those who did not. There was a trend towards higher AIS-extremity in patients who received ISA compared to those who did not, but it did not reach statistical significance (median of 3 (25 In total, there were 71 concomitant venous injuries (37%), of which 63 were repaired (89%). The remaining 8 injured veins were ligated. Sixty-three patients had concomitant nerve injuries (33%), and 66 patients had associated orthopedic injury (34%). There were no significant differences in concomitant venous or orthopedic injuries between patients who received ISA and those who did not. Patients with concomitant nerve injuries were less likely to receive ISA (26% with ISA vs. 43% without, p = 0.02).
RESULTS

Between
Forty-three patients had a pre-hospital tourniquet placed (22%). Most patients had an ischemia time (from time of injury to time of definitive repair) between 3 and 6 hours (54%, Table 2 ). Damage-control temporary shunt placement was used in 9 patients (5%) Patients who had an operative time of greater than 6 hours were more likely to receive ISA than not (10% vs. 5%, p = 0.04).
There were 96 and 97 injuries to the upper and lower extremity, respectively. There were no combined upper and lower extremity injuries, and no combined above-and below-knee arterial injuries. There were two combined brachial and radial injuries. ISA was given for popliteal arterial injuries in 84% (26/31) of cases, in 67% (39/58) of femoral and in only 38%
(3/8) of below-popliteal injuries (p < 0.001, Table 3 ). The total limb salvage rate was 94%
(182/193). Popliteal artery injuries had the lowest rate of limb salvage (84%, 26/31). Lower extremity amputations were more frequent than upper extremity amputations (10% of lower extremity injuries (10/97) vs. 1.0% of upper (1/96), p = 0.005). Rates of amputation and RTLA by artery injured and ISA status can be found in Table 3 . Results were not analyzed for statistical significance given small numbers per group.
RTLA occurred in 22 patients (11%), including 11 amputations and 13 instances of graft thrombosis (Table 4 ). There was no significant difference in RTLA between patients who received ISA and those that did not (12/119 (10%) vs. 10/74 (14%), p = 0.6).
There was significantly higher total blood product use among patients treated with ISA given ISA alone (p = 0.19) (7). Humphries et al. performed a modern retrospective review of 123 patients with extremity injuries, in which 56% of patients received ISA (6). They found no difference in RTLA with use of ISA (OR 0.74, p = 0.6) (6). Similarly, we found no significant association between ISA and amputation and/or repair thrombosis.
The limb salvage rate observed in this study is consistent with modern studies (9), with 94% limb salvage. Popliteal artery injuries continue to have the poorest limb salvage rates.
There is no appreciable improvement in the overall limb salvage rate of popliteal arteries since the 1980s; 84% in this modern study compared to historically reported rates of 83-100% (3-5, 7, 8, 13) despite improvements in hospital and pre-hospital care.
The biggest limitation of any database is the detailed information that are not collected.
Specifically, data regarding other adjuvant anticoagulation strategies including use of local heparinized-containing irrigation intraoperatively, transexemic acid, dextran, anticoagulation or antiplatelet agents given postoperatively, use of thrombectomy catheters, and details regarding specific ISA dose, pre-or post-administration activated clotting time levels were not collected in the PROOVIT database. These factors could be significant cofounding variables and warrant further investigation.
One main reason anticoagulation is withheld during arterial repair for a trauma patient is the concern for bleeding complications due to concomitant injuries. Anticoagulation given to patients with traumatic arterial injuries without absolute contraindications has been reported to have no increase in the rate of bleeding complications (5, 6, 9, 10, 14 and GCS between the groups. However, the outcomes of thrombosis, amputation, stroke or death were unchanged between the groups. The PROOVIT database does not currently include data regarding specific bleeding complications or strict contraindications for anticoagulation (i.e.
intra-cavitary hemorrhage, need for multiple operations), and therefore these potential confounders will be missed. This preliminary report focuses on in-hospital outcomes following traumatic arterial injury repair, and does not include delayed amputations that may be required long term for limb dysfunction, delayed repair thrombosis or infection. A power calculation determined that to detect a 3% difference in rate of amputation, 1496 total patients should be analyzed. A more 14 robust data set with information on outcomes will be obtained as the PROOVIT database continues to mature.
In this study, anticoagulation given during an operation was not associated with improved graft patency or limb salvage. Furthermore, ISA use was associated with prolonged hospital stay and increased blood product use. Our data suggest that for traumatic arterial injuries, there is no significant difference in outcome to support use of ISA. Further investigation regarding the risks of ISA for traumatic vascular injuries is needed.
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